-
Globus Medical Inc. Class A (GMED $58.65)
- $58.65 P/E (TTM): 40.35X Cap: $7.92B
- View GMED Profile
- View Questions on GMED
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Medtronic plc. (MDT $92.88)
- $92.88 P/E (TTM): 25.27X Cap: $119B
- View MDT Profile
- View Questions on MDT
-
Stryker Corporation (SYK $377.58)
- $377.58 P/E (TTM): 49.85X Cap: $144.35B
- View SYK Profile
- View Questions on SYK
-
Zimmer Biomet Holdings Inc. (ZBH $99.26)
- $99.26 P/E (TTM): 21.87X Cap: $19.66B
- View ZBH Profile
- View Questions on ZBH
-
Globus Medical Inc. Class A (GMED $58.65)
- $58.65 P/E (TTM): 40.35X Cap: $7.92B
- View GMED Profile
- View Questions on GMED
-
Penumbra Inc. (PEN $240.49)
- $240.49 P/E (TTM): 63.69X Cap: $9.35B
- View PEN Profile
- View Questions on PEN
Q: Who are competitors of STRYKER MEDTRONICS Which do you prefer ? RAK
-
Intuitive Surgical Inc. (ISRG $470.08)
- $470.08 P/E (TTM): 65.43X Cap: $168.51B
- View ISRG Profile
- View Questions on ISRG
-
Abbott Laboratories (ABT $134.28)
- $134.28 P/E (TTM): 16.57X Cap: $233.70B
- View ABT Profile
- View Questions on ABT
-
Edwards Lifesciences Corporation (EW $78.35)
- $78.35 P/E (TTM): 11.13X Cap: $45.99B
- View EW Profile
- View Questions on EW
-
Thermo Fisher Scientific Inc (TMO $460.72)
- $460.72 P/E (TTM): 26.3X Cap: $173.97B
- View TMO Profile
- View Questions on TMO
-
Zoetis Inc. Class A (ZTS $147.35)
- $147.35 P/E (TTM): 26.61X Cap: $65.30B
- View ZTS Profile
- View Questions on ZTS
-
IDEXX Laboratories Inc. (IDXX $658.06)
- $658.06 P/E (TTM): 60.08X Cap: $52.64B
- View IDXX Profile
- View Questions on IDXX
-
Globus Medical Inc. Class A (GMED $58.65)
- $58.65 P/E (TTM): 40.35X Cap: $7.92B
- View GMED Profile
- View Questions on GMED
-
Atrion Corporation (ATRI)
- P/E (TTM): 64.5X Cap: $809M
- View ATRI Profile
- View Questions on ATRI
-
InMode Ltd. (INMD $14.11)
- $14.11 Cap: $981M
- View INMD Profile
- View Questions on INMD
-
GE HealthCare Technologies Inc. (GEHC $72.00)
- $72.00 P/E (TTM): 14.54X Cap: $32.87B
- View GEHC Profile
- View Questions on GEHC
Q: Please rank these healthcare stocks in terms of long term growth potential (5-10 years or more): EW, ISRG, IDXX, GEHC, ZTS, ABT, TMO, ATRI, GMED, INMD
-
Intuitive Surgical Inc. (ISRG $470.08)
- $470.08 P/E (TTM): 65.43X Cap: $168.51B
- View ISRG Profile
- View Questions on ISRG
-
Johnson & Johnson (JNJ $173.33)
- $173.33 P/E (TTM): 18.35X Cap: $417.43B
- View JNJ Profile
- View Questions on JNJ
-
Globus Medical Inc. Class A (GMED $58.65)
- $58.65 P/E (TTM): 40.35X Cap: $7.92B
- View GMED Profile
- View Questions on GMED
-
Guardant Health Inc. (GH $54.23)
- $54.23 Cap: $6.76B
- View GH Profile
- View Questions on GH
-
Medpace Holdings Inc. (MEDP $434.35)
- $434.35 P/E (TTM): 31.88X Cap: $12.20B
- View MEDP Profile
- View Questions on MEDP
-
Fulgent Genetics Inc. (FLGT $20.36)
- $20.36 Cap: $623M
- View FLGT Profile
- View Questions on FLGT
Q: I want exposure to health. Looking for growth in the next 5 years. Can you please rate these companies in term of growth in next 5 years, starting with the most potential? And what is a good entry point for them?
Feel free to suggest any other health care stock that offer growth as well. Thank you very much.
Feel free to suggest any other health care stock that offer growth as well. Thank you very much.
Insiders
Share Information
SEC Filings
News and Media